IBT
International Biotechnology Trust Portfolio holdings
AUM
$297M
This Quarter Return
+14.86%
1 Year Return
+17.25%
3 Year Return
+11.14%
5 Year Return
+79.35%
10 Year Return
–
AUM
$366M
AUM Growth
+$366M
(+18%)
Cap. Flow
+$31.2M
Cap. Flow
% of AUM
8.51%
Top 10 Holdings %
Top 10 Hldgs %
57.01%
Holding
57
New
4
Increased
13
Reduced
4
Closed
5
Top Buys
1 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$14.3M |
2 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
$9.56M |
3 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$8.9M |
4 |
Vertex Pharmaceuticals
VRTX
|
$7.67M |
5 |
Amgen
AMGN
|
$6.44M |
Top Sells
1 |
Neurocrine Biosciences
NBIX
|
$18.9M |
2 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$8.98M |
3 |
IMMU
Immunomedics Inc
IMMU
|
$4.22M |
4 |
Iovance Biotherapeutics
IOVA
|
$4.04M |
5 |
Biogen
BIIB
|
$2.64M |
Sector Composition
1 | Healthcare | 95.25% |